ASSESSING THE QUALITY OF PHARMACEUTICAL CARE .2. APPLICATION OF CONCEPTS OF QUALITY ASSESSMENT FROM MEDICAL-CARE

被引:40
作者
FARRIS, KB
KIRKING, DM
机构
[1] UNIV MICHIGAN, COLL PHARM, ANN ARBOR, MI 48109 USA
[2] UNIV MICHIGAN, SCH PUBL HLTH, ANN ARBOR, MI 48109 USA
关键词
D O I
10.1177/106002809302700218
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To present a framework that facilitates quality assessment of pharmaceutical care (PC) so that the profession and the public may identify pharmacists in ambulatory settings who provide quality care in all aspects of their practices. DATA SOURCES: A MEDLINE search augmented by a review of International Pharmacy Abstracts was used to identify pertinent quality assessment and pharmacy practice literature; indexing terms included quality assurance, healthcare, pharmacists, community pharmacy services, ambulatory, pharmacy, and process and outcome assessment. STUDY SELECTION: All identified quality assessments of community pharmacy practice were considered. Studies that documented the effectiveness of specific pharmacist activities and patient satisfaction were also included. DATA EXTRACTION: The literature was independently reviewed by the primary author. DATA SYNTHESIS: The structure-process-outcome paradigm is presented as a framework for quality assessment of PC. Structure should be assessed at periodic intervals because it identifies the potential for the provision of quality care. Process, the care that pharmacists provide, must be documented and linked to outcomes before either structure or process can be used to make inferences about the quality of PC. Technical and interpersonal processes should be examined. Outcomes require an interdisciplinary approach that not only considers other medical care inputs but also recognizes the psychologic, economic, and social factors that affect health status and quality of life. Process and outcome must both be assessed to distinguish the contribution of pharmacists from that of other healthcare providers. Examples of criteria are provided and a model to integrate PC within the healthcare system is discussed. CONCLUSIONS: It is pharmacists' duty to ensure that patients receive an acceptable level of PC. The structure-process-outcome paradigm provides a framework to identify and link pharmacists' processes with patients' outcomes.
引用
收藏
页码:215 / 223
页数:9
相关论文
共 53 条
[1]  
ASCIONE FJ, 1984, DRUG INTEL CLIN PHAR, V18, P926, DOI 10.1177/106002808401801121
[2]  
BOYD JA, 1990, AM PHARM NS, V30, P420
[3]   CLONIDINE CONFUSED WITH CLONOPIN [J].
BRENNAN, MJW ;
GUTRECHT, JA ;
HEISS, FW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 252 (13) :1681-1681
[4]  
BROOK R, 1975, DRUGS HLTH CARE, V2, P57
[5]  
BROOK RH, 1977, MED CARE, V15, P1
[6]   STUDIES OF PROCESS-OUTCOME CORRELATIONS IN MEDICAL-CARE EVALUATIONS [J].
BROOK, RH .
MEDICAL CARE, 1979, 17 (08) :868-873
[7]  
BROOK RH, 1986, NITS HRP0017082 RAND
[8]   9-YEAR EXPERIENCE WITH A PHARMACIST-MANAGED ANTICOAGULATION CLINIC [J].
CONTE, RR ;
KEHOE, WA ;
NIELSON, N ;
LODHIA, H .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1986, 43 (10) :2460-2464
[9]  
Davis N M, 1990, Hosp Pharm, V25, P18
[10]  
Davis N. M., 1990, HOSP PHARM, V25, P28